Search tips
Search criteria 


Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2010; 5(8): e12181.
Published online 2010 August 17. doi:  10.1371/journal.pone.0012181
PMCID: PMC2923157

A Transposon in Comt Generates mRNA Variants and Causes Widespread Expression and Behavioral Differences among Mice

Jörg Hoheisel, Editor



Catechol-O-methyltransferase (COMT) is a key enzyme responsible for the degradation of dopamine and norepinephrine. COMT activity influences cognitive and emotional states in humans and aggression and drug responses in mice. This study identifies the key sequence variant that leads to differences in Comt mRNA and protein levels among mice, and that modulates synaptic function and pharmacological and behavioral traits.

Methodology/Principal Findings

We examined Comt expression in multiple tissues in over 100 diverse strains and several genetic crosses. Differences in expression map back to Comt and are generated by a 230 nt insertion of a B2 short interspersed element (B2 SINE) in the proximal 3′ UTR of Comt in C57BL/6J. This transposon introduces a premature polyadenylation signal and creates a short 3′ UTR isoform. The B2 SINE is shared by a subset of strains, including C57BL/6J, A/J, BALB/cByJ, and AKR/J, but is absent in others, including DBA/2J, FVB/NJ, SJL/J, and wild subspecies. The short isoform is associated with increased protein expression in prefrontal cortex and hippocampus relative to the longer ancestral isoform. The Comt variant causes downstream differences in the expression of genes involved in synaptic function, and also modulates phenotypes such as dopamine D1 and D2 receptor binding and pharmacological responses to haloperidol.


We have precisely defined the B2 SINE as the source of variation in Comt and demonstrated that a transposon in a 3′ UTR can alter mRNA isoform use and modulate behavior. The recent fixation of the variant in a subset of strains may have contributed to the rapid divergence of inbred strains.


Degradation of the catecholamine neurotransmitters dopamine, epinephrine, and norepinephrine is catalyzed by catechol-O-methyltransferase (COMT) and the monoamine oxidase enzymes. The mechanism of transmitter inactivation is distinct for each enzyme—methylation for COMT and deamination for monamine oxidase—and the impact each exerts on neurotransmitter tone varies by brain region. COMT is a key enzyme regulating dopamine tone in frontal neocortex in which expression is high relative to the monoamine oxidases and dopamine transporters, but COMT contributes less to dopamine tone in the striatum and nucleus accumbens [1], [2], [3], [4]. Dopamine levels play a critical role in the modulation of cognitive and emotional states, and changes in dopamine signaling are hallmarks of many psychiatric and addiction disorders. In humans, non-human primates, and rodents dopamine levels and cognitive performance have been described by an inverted U-shaped relation in which too much or too little extracellular dopamine has detrimental effects [5], [6], [7].

Multiple SNPs have been identified that lead to changes in mRNA, protein, and/or activity levels but a single allele (Val108/158Met) accounts for most of the variation in the level of COMT activity in humans. Individuals homozygous for the Met allele have a 3- to 4-fold reduction in COMT activity and increased prefrontal cortex dopamine levels [8]. Although mice lack this particular polymorphism, several recent studies have shown that variation in Comt mRNA level [9] and activity [10] between C57BL/6J (B6) and DBA/2J (D2) mouse strains is associated with differences in aggression level and morphine sensitivity, respectively.

The B6 and D2 strains differ greatly on a wide variety of traits and their genomes are highly polymorphic with approximately 5 million identified sequence variants ( and A genetic reference population of B6 X D2 (BXD) recombinant inbred lines made by crossing these parental strains has been used extensively to explore differences in gene expression, neuropharmacology, and behavior, often using quantitative trait locus (QTL) mapping methods [11], [12]. The expression of Comt in this family of strains varies over 2-fold in several CNS regions and is strongly modulated by a polymorphism located within Comt itself [13]. However, there are no known SNPs between B6 and D2 in Comt, and the gene is situated in a ~8 Mb region that is identical by descent among most inbred strains. The genetic mechanism of the observed variation in Comt expression has been an unresolved question. In this paper we report the cloning of the cis sequence variant that controls Comt mRNA expression in many inbred strains and that produces widespread effects in the BXD family. The cause of this Comt cis-regulation is the insertion of a strong and premature polyadenylation signal in the proximal 3′ UTR in B6 and several other strains. As a consequence these strains produce short 3′UTRs compared to strains without the insertion. This is the first known variant in mice that causes variation in Comt expression. This mutation has effects on COMT activity and is clearly linked to downstream variation in expression of many other genes, dopamine tone, and behavior. We find both expected and novel biological roles for Comt that are relevant for the diagnosis and treatment of psychiatric and cognitive diseases in humans.


Variation in Comt mRNA expression and cis-regulation in CNS and peripheral tissues

We measured expression of Comt across multiple tissues in over 100 strains of mice and several large F2 intercrosses using four microrray platforms. Between strains and across tissue we consistently detect large differences in expression for probe sets that target both coding exons and the distal 3′ UTR (Fig. 1A, Figure S1, and Figure S2). We mapped this variation in Comt expression in several crosses, including the large BXD family. In this family, Comt expression maps to the location of the Comt gene itself (Fig. 1C and Fig. 1D). Such differences that map back to the physical location of the gene are referred to as cis-regulated QTLs. For example in kidney, variation in the distal 3′ UTR of the gene (probe set 1418701_at) maps to chromosome (Chr) 16 with an extremely high likelihood of the odds (LOD) score of 30 and a 2-LOD support interval from 17.5 to 19.8 Mb (Fig. 1D). This demonstrates that sequence variants in or around the Comt gene control its expression. In this case, each copy of the D2 (D) allele increases Comt mRNA signal by a factor of two (Fig. 1B and

Figure 1
Cis modulation of Comt expression by B and D alleles in different tissues.

The expression of mRNA containing the distal 3′ UTR (probe set 1418701_at) is strongly cis-modulated in all tissues and is associated with high expression from the D allele. In contrast, expression of more proximal coding exons (probe set 1449183_at) is not as strongly cis-regulated, is more variable across brain regions and organs, and is usually associated with higher expression from the B6 (B) allele (Fig. 1B). Mean expression of the coding exons is higher and less variable among BXD strains than expression of the distal 3′ UTR in all tissues (Fig. 2). For example, there is over 44-fold variation in distal 3′ UTR expression between the B and D alleles in the kidney compared to a 4-fold difference in coding exons from the same tissue. The pattern of high expression from the B allele for more proximal probe sets and high expression from the D allele for distal 3′ UTR probe sets was replicated in the hippocampus and striatum using different microarray platforms (Figure S3).

Figure 2
Expression of Comt coding exon and distal 3′ UTR in the BXD population across tissues.

Profound differences in Comt expression were detected among highly diverse inbred strains of mice (Figure S1, Figure S2). Like B6, a small number of other common inbred strains, including 129S1/SvImJ, BALB/cByJ, A/J (A), C57BL/6ByJ, and AKR/J (AK), have low expression using the distal 3′ UTR probe set. In contrast, and like D2, a larger number of strains, including C3H/HeJ (H), CBA/CaJ, FVB/NJ, KK/HlJ, NZO/HlLtJ, NZW/LacJ, SJL/J, and all wild subspecies, have high expression. All crosses derived from strains that differed in Comt expression show strong cis-modulation. For example, progeny of crosses between B6 and H, B6 and CAST/EiJ, and AK and D2 demonstrate cis-modulation whereas progeny of crosses between B6 and A, and C57BL/6ByJ and BALB/cByJ do not (Table S1).

Collectively, these diverse mapping data sets demonstrate that expression of Comt is strongly cis-regulated and is caused by sequence variation in or around Comt itself. Surprisingly, B6, D2, and the great majority of strains are identical by descent for a large interval surrounding Comt. There are no known SNPs in Comt between B6 and D2 (Fig. 3) and only 212 total SNPs between 15 and 23 Mb. The persistence of strong cis-modulation in the absence of SNPs provided a unique opportunity to identify the cryptic, but causal sequence variant in Comt.

Figure 3
C57BL/6J and DBA/2J are identical by descent for a large region on chromosome 16 surrounding Comt.

Sequencing of the Comt locus

Next-generation whole genome sequencing data has recently been completed for the D2 strain using Applied Biosystems SOLiD and Illumina GA2 sequencing platforms (whole genome shotgun coverage of ~52x). A complete compendium of new D2 SNPs and other sequence variants in and around Comt is available at GeneNetwork ( and from the Wellcome Trust Sanger Institute ( We identified large numbers of structural variants (copy number variants, translocations, inversions, and insertions and deletions) between B6 and D2, but none in the Comt interval. The sole exception was a 230 bp deletion in D2 (Figure S4). This insertion/deletion (indel) was located in the proximal 3′ UTR (Chr 16 from 18,407,621–18,407,392 Mb). We sequenced the region around the indel in 8 strains with high or low expression (Fig. 4) and B6 and D2 reciprocal F1 hybrids. The presence or absence of the indel corresponded to the expression level detected by the distal 3′ UTR probe set (1418701_at). Strains with the insertion, B6, BXD31, LG/J, and A/J (not shown), have low expression whereas strains without the insertion, D2, BXD76, PWK/PhJ, and KK/HIJ (not shown), have high expression.

Figure 4
A 230 bp insertion in the proximal 3′ UTR of Comt is present in multiple strains.

To rule out the possibility that other sequence variants regulate Comt we queried genomic sequence data from seventeen inbred strains available from the Sanger Institute. We found no SNPs, indels, or haplotypes that segregate with the pattern of expression for a ±2 Mb interval surrounding Comt. The only exception is an isolated indel that segregates perfectly among all strains with high or low distal 3′ UTR expression. This indel is the only viable candidate for the massive cis-QTL in Comt. For this reason we closely examined this variant to understand the mechanisms that generate the strong cis eQTL.

Characterization of the 3′ UTR indel in the comt locus

The 230 bp indel is a repetitive B2 family short interspersed element (SINE). B2 SINEs are a common type of retrotransposon representing ~2.4% of the mouse genome [14]. The B2 sequence contains several typical features, including a split RNA polymerase III promoter and termination signal. Of greater significance, this element also contains an array of overlapping polyadenylation signals flanked by an adenosine (A) rich segment in the 3′ region [15], [16], [17] (Fig. 5A). The insertion of this element and several premature polyadenylation sites in a subset of strains, including B6, should generate mRNA containing a shorter 3′ UTR. In contrast, D2 and other strains that do not contain the SINE, should use the more distal and highly conserved polyadenylation site, and therefore produce a longer 3′ UTR. We used 3′ RACE and RNA sequencing (RNA-seq) to test the effect of the introduced polyadenylation signal on 3′ UTR length. As expected, the B6 strain produced a much shorter 3′ UTR compared to D2 (Fig. 5B) and there was a marked reduction in mRNA containing the distal 3′ UTR in B6 (Figure S5).

Figure 5
Insertion of a B2 SINE containing an alternative polyadenylation site into the Comt gene leads to the production of mRNA containing a shorter 3′ UTR in B6.

The insertion of the B2 SINE produces variation in 3′ UTR length that segregates among BXD strains and is the sole cause of cis-regulation of Comt expression. In the BXD panel, probe set measurements based on the distal 3′ UTR detect the presence or absence of the long 3′ UTR isoform and show consistent allelic regulation of expression (Figure S1, Figure S2). Probe sets that target coding exons do not discriminate between isoforms and more accurately reflect overall strain and tissue differences in total mRNA level. The genetic control of these probe sets was tissue specific. For example, highest expression of coding exons in the cerebellum, hippocampus, and striatum was associated with the B allele, whereas in prefrontal cortex and kidney, higher expression was generally associated with the D allele (Fig. 1B and Fig. 2). This demonstrates that transacting factors and tissue specific trans-QTLs are also important modulators of Comt expression.

Independent of variation in total Comt levels, strains with the B2 SINE insertion primarily produce Comt with a short 3′ UTR and strains without the insertion produce Comt with a long 3′ UTR. It is possible that these differences in 3′ UTR length have a functional consequence on protein level. In rodent brain a single transcript codes for both soluble (S-) and membrane bound (MB-) COMT through a leaky scanning mechanism [18]. We compared the level of both protein isoforms between strains in hippocampus and prefrontal cortex and both are expressed more highly in B6 (Fig. 6). Regardless of relative mRNA abundance between strains, B6 mRNA containing the shorter 3′ UTR is associated with higher levels of COMT protein expression.

Figure 6
The level of COMT protein differs between the B6 and D2 strains.

Impact of Comt gene sequence variation on downstream biological functions

What sets of higher order phenotypes are downstream of the Comt polymorphism? To answer this question we extracted all classical phenotypes in the GeneNetwork BXD phenotype database that map within 2 Mb of Comt. The prior probability of mapping near Comt is unusually low because this region is small (0.16% of the genome) and, with the exception of the B2 SINE polymorphism, is identical by descent (Fig. 3). Even in massive expression data sets no more than 1–2 transcripts are expected to map to this region by chance. Twelve classical phenotypes with high content validity map to the Comt locus (p<0.02, Table S2), including binding affinity of both dopamine receptors (DRD1 and DRD2) in caudate, nucleus accumbens, ventral tegmental area, and prefrontal cortex [19]. Linkage of DRD1 and DRD2 binding was sex-specific and only detected in males. Sensitivity to the dopamine receptor antagonist haloperidol [20] and chloradiazepoxide, an allosteric modulator of GABA-A receptors [21], also map to Comt.

To explore intermediate networks between Comt and the classic phenotypes listed above, we extracted transcripts modulated by Comt in four brain regions (Fig. 7, Table S3). Transcripts and genes with trans QTLs mapping into the Comt locus were filtered by expression level, biological relevance, and by examining expression in the Allen Institute for Brain Science (AIBS) brain atlas ( Downstream targets of Comt participate in cytoskeletal regulation (Cmip, Etnk1, and Ptprd), intracellular signaling (Cdc42, Araf, Hipk2, Cmip, Etnk1, Ptprd, and Rasgrp1), transport (Stau1, Adam10, Dnajc10, Mcoln1, Golga3, Arl7, Spo, Pitpnb, Ddx47, Capns1, and Kif5a), receptor/channel trafficking (Palm, Akap9, Sqstm1, Cntn2, Nsg1, and Dlgap1), synaptic maintenance and plasticity (Apba1, Tle3, Slit3, Slc12a6, Elavl4, and Syt1), transcriptional regulation (Nipbl, Myt1l, Ncor1, Jundm2, and Tef), and catecholamine metabolism (Maoa). Given the marked differences in expression of Comt covariates in different tissues and organs, we neither expected nor did we find significant overlap of its downstream targets. One exception was receptor protein tyrosine phosphatase delta (Ptprd). A key signaling molecule in the CNS involved in neurite growth [22], deletion of Ptprd leads to learning and feeding impairments, in addition to alterations in hippocampal long-term potentiation [23]. There was significant overlap in gene function across data sets. Well supported categories included receptor trafficking, and synaptic maintenance/plasticity. Each region also included key genes associated with addiction (Maoa, Ptprd, and Slit3), psychiatric illnesses (Maoa, Myt1l, Slc12a6, and Slit3), and neurodegenerative diseases (Apba1 and Slc12a6).

Figure 7
Comt regulatory model.


In this study we have identified the sequence variant underlying a strong cis-acting expression quantitative trait locus (eQTL) for the Comt gene. Comt is located in a large interval that is otherwise devoid of sequence variants between the BXD strains. In combination with strong mapping data, this provides definitive genetic and sequence support that the insertion of the B2 SINE into the proximal 3′ UTR is the ultimate cause of the Comt eQTL. Based on expression data and corroborative sequence data, wild derived strains (MOLF/EiJ, CAST/EiJ, PWK/PhJ, and PWD/PhJ) and Swiss mice (FVB/NJ and SJL/J) lack the insertion. Some strains derived from W. E. Castle and C. C. Little's stocks contain the insertion (C57BL/6J, A/J, 129S1/SvlmJ, and BALB/cByJ) whereas others do not (DBA/2J, 129P3/J, CBA/J, and C58/J). In the absence of the B2 SINE, inbred strains produce mRNA with a long 3′ UTR. The insertion introduces a premature polyadenylation site and the production of a short isoform. The propagation of the B2 SINE in several strains derived by Castle and Little, as well as its absence in wild derived strains, is evidence that the long 3′ UTR is ancestral. The short isoform is likely the result of a transposition fixed by inbreeding in the early 1900s. This naturally occurring mutation is likely to be the major source of variation in Comt expression among inbred strains.

The B2 SINE is associated with higher expression of Comt coding exons in B6 relative to D2 in the cerebellum, hippocampus, and striatum but not in the prefrontal cortex, ventral tegmental area, and nucleus accumbens. The B2 SINE insertion accounts for over 90% of the variance in mRNA length and expression across tissues but it is not the only mechanism governing expression. Approximately 50% of the variance of the common coding form is due to segregating trans-effects, non-segregating masking epistatic interactions, and residual error. Intriguingly, our protein analysis reveals that mRNA containing the short 3′ UTR is translated at a higher level than mRNA containing the longer 3′ UTR, regardless of relative isoform abundance in different tissues. This effect may be mediated by differences in secondary structure between isoforms, preferential binding to each isoform by factors regulating transport or translation, or by isoform differences in polyadenylation. The net result however is that the B2 SINE, by causing a change in the length of the 3′ UTR, contributes significantly to genetic variation in COMT protein abundance. An increase in total COMT could be associated with higher enzymatic activity and previous research has demonstrated significantly higher COMT activity in the nucleus accumbens and prefrontal cortex of the B6 strain compared to D2 [10]. These results demonstrate a link between genomic sequence variation, transcript abundance, protein level, and enzymatic activity.

Variation in Comt message and protein levels caused by the B2 SINE influences multiple neurotransmitter systems, and has known and novel downstream effects on neuronal signaling and behavior (Fig. 7). Key genes regulated by Comt are involved in catecholamine metabolism (Maoa), nervous system maintenance (Slc12a6), the excitatory postsynaptic density (Dlgap2), and receptor trafficking of AMPA (Palm, Sqstm1, and Nsg1) and NMDA (Akap9 and Apba1) receptors. The Comt downstream network also modulates synaptic transport (Stau1, Elavl4, Kif5a, and Syt1) and intracellular signaling (Hipk2, Araf, Cmip, and Etnk1). As expected, dopaminergic systems are clearly downstream of Comt, including Maoa in the striatum, DRD1 and DRD2 binding density in multiple brain regions, and the response to the dopamine receptor antagonist haloperidol. Finally, Comt modulates components of the glutamatergic and GABAergic systems and is linked to the expression of genes involved in excitatory synapse maintenance and locomotor responses to chlordiazepoxide, an allosteric modulator of GABA-A receptors.

The Comt variant exposes interconnectivity among neurotransmitter systems. From one perspective this may be surprising given the role of this enzyme in catecholamine catabolism, but even small changes at the end of a biochemical cascade feed back on transmitter synthesis and receptor trafficking to maintain homeostasis. Polymorphisms in COMT are often associated with CNS diseases such as schizophrenia, anorexia nervosa, bipolar disorder, anxiety, and substance use disorders [24]. These complex diseases have comparatively high genetic complexity, population heterogeneity, overlapping diagnostic criteria, modest additive effects of single polymorphisms, and a high likelihood that epistatic interactions influence disease risk [25], [26], [27], [28], [29]. The more widespread use of joint studies of mouse and human populations will provide an effective translational bridge. Genes and pathways that we have identified as sensitive to Comt variation in mice are attractive candidates in humans. Similarly, genes and pathways identified in human families and genome-wide association studies are attractive candidates to study using mouse reference populations.

There is significant divergence in COMT sequence and activity between mice and humans. A more efficient first initiation site in human COMT mRNA leads to the production of more membrane bound MB-COMT than soluble S-COMT in human brain [30] which, despite having a lower enzyme capacity, has a higher affinity for dopamine and other neurotransmitters [31], [32], [33]. In contrast, mice express both protein isoforms abundantly in brain. In humans multiple SNPs have been identified that lead to changes in mRNA, protein, and enzyme activity. In contrast, common strains of mice have little variation in Comt sequence, the B2 SINE, excepted. Additionally, mouse COMT, which contains Leu instead of Val at the equivalent position as the human Val108/158Met polymorphism, has higher activity than the Val allele [8]. In fact, amino acid substitution from Leu in mice to Val in monkeys and Met in humans substantially reduces COMT activity. This results in increased brain dopamine signaling in humans with important cognitive consequences. For example, Met polymorphisms, which decrease COMT activity, enhance working memory and attention [5], [34], [35], [36], [37], [38], [39]. However, the Met allele is associated with less pain and stress resiliency compared to the Val allele [40]. Despite the differences in the genetic regulation of Comt between mouse and human, manipulations point to very similar roles in cognition and behavior. Consistent with human studies, disruption of Comt in male mice elevates dopamine levels in the prefrontal cortex [2] and enhances working memory [30]. Conversely, overexpression of human COMT containing the Val polymorphism in mice leads to the disruption of working memory and attention and a reduction in sensitivity to pain and stress [30].

Mammalian genomes contain a large proportion of transposable elements (TEs), including the Alu family of SINEs in humans, and B1 and B2 SINEs in rodents. TE insertions, such as the B2 SINE in Comt, are important drivers of gene evolution [16], [41]. Approximately 7% of genes in mice contain non-conserved polyadenylation sites derived from TEs [41]. These polyadenlyation sites can be co-opted to create novel mRNA structures that effect message processing, distribution, and translation. As in the case of Comt, insertion of a B2 SINE in the 3′ UTR of major histocompatibility complex genes results in preferential usage of a premature polyadenylation signal [15]. Given the abundance of B1 and B2 SINES—564,000 and 348,000 copies, respectively [14]—it is highly likely that insertions of TEs modulate the expression of several other genes. These types of mutations, combined with intense selection, may have contributed to the rapid behavioral evolution of both wild populations and laboratory strains [42].


Ethics statement

All animal work was conducted according to an approved animal use protocol (UTHSC680) and in accordance with procedures approved by the Institutional Animal Care and Use Committee.

Expression and QTL analysis of Comt using GeneNetwork

Multiple expression datasets from many brain and peripheral tissues of inbred and RI strains were used in this analysis (see Text S1 for additional methods). Additional detailed descriptions of strain, sex, tissue preparation and microarray method for each individual database is available at Four microarray platforms were used in this analysis including; Agilent, Illumina, Affymetrix Exon 1.0 ST, and M430 arrays. Tools for QTL mapping and visualization are available at [43], [44].

Comt 3′ UTR genomic DNA isolation and sequencing

Mice were purchased from Jackson Laboratory or bred in-house. Mice were housed at the University of Tennessee Health Science Center in a pathogen-free colony in accordance with procedures approved by the Institutional Animal Care and Use Committee. Naive B6, D2, BXD31, BXD76, B6D2F1, D2B6F1, A/J, LG/J, PWK/PhJ, and KK/HlJ mice were killed at about 60 days of age by cervical dislocation.The liver was immediately collected and stored in RNALater (Ambion) at 4°C overnight. Genomic DNA was isolated using DNeasy Kits (QIAGEN) We used Primer 3 software to design custom forward (5′-GCG CCA TCA TAC CTG AAA AG-3′) and reverse (5′-GGA AAA CAC CTG TGC ATCA A-3′) primers specifically targeting Comt 3′ UTR genomic DNA for amplification by PCR. PCR product size was predicted to be 608 bp based on available genomic data for the B6 reference strain. Coverage area within the Comt locus was from 18,407,151 to 18,407,758 Mb. DNA amplification was performed using the HotStar HiFidelity Polymerase kit (Qiagen) and 10 ng of genomic DNA for each strain followed by sequencing of the PCR products with each custom primer using an A3130XL Genetic Analyzer (Applied Biosystems). The resulting sequences were aligned against reference sequences from the NCBI GenBank database using nucleotide blast. The sequences were also aligned between strains using BLAST (bl2seq). The genomic DNA sequence of the Comt 3′ UTR for the D2 strain is available at GenBank (GU324996).

Expression analysis using RNA -seq

Total RNA was isolated from the whole brains of 27BXD RI strains using RNA STAT-60 (Tel-Test Inc). Samples were DNase treated using a DNA-free kit (Ambion) to eliminate genomic DNA. The quality and purity of total RNA from each sample was assessed using an Agilent Bioanalyzer 2100 system. For RNA-seq, ribosomal RNA (rRNA) was removed from each total RNA sample using the RiboMinus Eukaryote Kit (Invitrogen). Each RNA sample was then converted to cDNA and amplified. Emulsion PCR was performed for each sample and each fragment library was subsequently sequenced on the Applied Biosystems SOLiD platform. This procedure preserves the strandedness (plus or minus) of the RNA read.

RNA-seq data processing and visualization

Short sequence reads were analyzed using Applied Biosystems whole transcriptome software tools ( were mapped to the B6 reference genome (mm9, US National Center for Biotechnology Information (NCBI) build 37) with a minimum alignment score of 24.

Isolation and sequencing of Comt 3′ UTR mRNA

RNA STAT-60 (Tel-Test Inc) was used for RNA extraction from B6 and D2 hippocampus followed by ethanol precipitation. RNA quality was determined using a NanoDrop spectrophotometer (Thermo Scientific) and Agilent Bioanalyzer 2100 (Agilent). Target cDNA was generated using the FirstChoice RLM-RACE kit (Ambion) with minor modifications to the standard protocol (Text S1). The amplified products for each strain were purified with a PCR purification kit (Qiagen) and sequenced using both Comt 3′ UTR forward primer and the 3′ RACE inner primer separately. The mRNA sequence data for the B6 and D2 strain is available at GenBank (GU324998 contains B6 3′ UTR mRNA sequence and GU324997 contains D2 3′ UTR mRNA sequence). The full length of the 3′ UTR is 553 and 789 nt for the B6 and D2 strain, respectively.

Protein extraction and immunoblotting

Fresh brain tissue from the hippocampus and prefrontal cortex was dissected from B6 and D2, snap-frozen in liquid nitrogen, and stored at −80°C followed by protein extraction (Text S1). Aliquots were created from each total protein extract and stored at −80°C until used for immunoblotting. Six total protein samples each from the hippocampus and prefrontal cortex of the B6 and D2 strain were used. Fifteen ug of protein was loaded on a NuPAGE 4−12% Bis-Tris Gel (Invitrogen). Protein samples were separated by electrophoresis at 150 volts for 45 min before transferring to a PVDF membrane. Immunoblotting was performed using the WesternDot 625 goat anti-mouse Western blot kit (Invitrogen) according to the manufacturer's instructions (Text S1). Primary antibodies used in immunoblotting were mouse anti-COMT (clone 4/COMT, aa 26–141) and mouse anti-actin Ab5 (BD Transduction Laboratories). Images were acquired with an AlphaImager HP (Alpha Innotec).

Mapping traits to the Comt locus

We used a point-wise p-value of <0.02 (LOD>1.73) to identify traits downstream of Comt. Phenotypes within the BXD Phenotype database were correlated with marker rs4165069 followed by marker regression to select traits with a significant marker association. Probe sets mapping to Comt were identified using the advanced search option in GeneNetwork across several Affymetrix M430 and Exon brain databases (Text S1). The advanced search option was used to detect probe sets with at least an LRS of 8 (LOD>1.73; p<0.02) and a mean expression level of 8 and 11 in the M430 and exon databases, respectively. False discovery rates for eQTL were conditioned by the likelihood that traits would map near Comt based on a target interval of 4 Mb and the relative density of sequence variants that produce eQTLs. Given these priors we expected less than 2 trans eQTL would map to the Comt interval by chance. Out of 24, 60, 18, and 30 probe sets mapping to the Comt locus in the hippocampus, striatum, prefrontal cortex and nucleus accumbens, respectively, we used our filtering criteria to select the 10 strongest traits controlled by variation in Comt from each region. Top probe sets were selected based on probe set specificity, strength of association to the Comt locus, biological function, and expression pattern for each relevant brain region in the AIBS (

Supporting Information

Figure S1

Strain variation in expression of distal 3′UTR Comt mRNA in whole brain and hippocampus. Mean log 2 expression values depicted above on the y-axis are from the UCHSC BXD Whole Brain M430 2.0 (Nov06) RMA database and the Hippocampus Consortium M430v2 (Jun06) RMA. Strains are indicated by the x-axis. Average expression across databases is 8 log2 units. Arrows indicate parental strains and numbers indicate recombinant inbred line (e.g. 40 = BXD40). (A) Both BXD and other inbred strains separate into two expression groups with either B6-like low expression or D2-like high expression of Comt mRNA containing distal 3′UTR sequence in the whole brain. (B) The same pattern of expression is observed in the hippocampus for BXD and other inbred strains. BXD and CXB parental strains are designated by the red and black arrows, respectively. When strains that share the same distal 3′ UTR mRNA expression pattern are crossed, as in the CXB strains (C57BL/6ByJ x BALB/cByJ), no expression differences are observed.

(0.56 MB TIF)

Figure S2

Strain variation in expression of coding exon Comt mRNA (1449183_at) in whole brain and hippocampus. Mean log 2 strain expression values are shown on the y-axis from the (A) UCHSC BXD Whole Brain M430 2.0 (Nov06) RMA database and the (B) Hippocampus Consortium M430v2 (Jun06) RMA. Strains are identified on the x-axis. Average expression across databases is 8. Individual BXD lines are identified by a number only (e.g., 16 = BXD16). There is a wide range of strain variation in the expression of coding exon mRNA which detects all expressed isoforms of Comt mRNA. Although there are high and low expressing strains, segregation into two distinct expression groups is not as readily apparent as was observed for the expression of the distal 3′ UTR. Black and red arrows indicate parental strains for the BXD and CXB strains (C57BL/6By x BALB/cBy), respectively.

(0.68 MB TIF)

Figure S3

Replication of Comt expression and genetic regulation in the hippocampus using Affymetrix Exon 1.0 ST arrays. (A) Location of probe sets to the distal 3′ UTR (4989545) and the last exon (5131400) of Comt based on BLAT search in the UCSC Genome Browser Mouse July 2007 Assembly (mm9). (B) Both probe sets are strongly cis-regulated from a region on chromosome 16 near the physical location of the Comt gene. (C) The B allele drives expression of the last exon while the D allele drives expression of the distal 3′ UTR.

(0.28 MB TIF)

Figure S4

Sequence alignment of C57BL/6J (B6) and DBA/2J (D2) genomic DNA in the chromosome 16 region containing the indel. There is a 230 bp insertion in the B6 strain, absent in the D2 strain. Red and black indicate genomic sequence from the D2 and B6, respectively. The corresponding genomic position is based on the (-) strand for the B6 reference strain. Dashes indicate the indel position.

(0.24 MB TIF)

Figure S5

Validation of the effect of the B2 SINE insertion on distal 3′ UTR expression by RNA-seq. RNA sequencing was performed on whole brain samples from 27 BXD strains as described in the methods. Strains were subdivided into a B or D allele group for the Comt locus based on genotype at marker rs4165081. The B allele group included 10 strains and the D allele group included17 strains. The Comt locus was subdivided into six features and the total number of 50-nt sequence tags mapping to each feature was determined for all strains. Tag counts were normalized by dividing by the total number per million in each sample. Normalized tag counts are shown for the B and D allele for each feature. A t-test revealed a significant difference between the B and D allele for the distal 3′ UTR (p = 0.015; **) and the second to last coding exon (p = 0.044; *). No sequence tags map exclusively to the B2 SINE because it is a repetitive element and similar sequences are scattered throughout the genome.

(0.13 MB TIF)

Table S1

Summary of Comt regulation.

(0.03 MB DOC)

Table S2

Published phenotypes mapping to the Comt locus.

(0.04 MB DOC)

Table S3

BXD exon and M430 top probe sets mapping to the Comt locus.

(0.26 MB DOC)

Text S1

Supplemental methods.

(0.07 MB DOC)


Competing Interests: The authors have declared that no competing interests exist.

Funding: This work was supported by grants from the National Institute on Drug Abuse (P20-DA 21131) and the National Institute on Alcohol Abuse and Alcoholism (U01AA13499, U24AA13513, U01AA016667, and U01AA014425) to RWW, MFM, and LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


1. Tunbridge EM, Bannerman DM, Sharp T, Harrison PJ. Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci. 2004;24:5331–5335. [PubMed]
2. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, et al. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A. 1998;95:9991–9996. [PubMed]
3. Karoum F, Chrapusta SJ, Egan MF. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J Neurochem. 1994;63:972–979. [PubMed]
4. Huotari M, Gogos JA, Karayiorgou M, Koponen O, Forsberg M, et al. Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice. Eur J Neurosci. 2002;15:246–256. [PubMed]
5. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, et al. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A. 2003;100:6186–6191. [PubMed]
6. Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AF. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci. 2007;10:376–384. [PubMed]
7. Goldman-Rakic PS. The cortical dopamine system: role in memory and cognition. Adv Pharmacol. 1998;42:707–711. [PubMed]
8. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet. 2004;75:807–821. [PubMed]
9. Fernandes C, Paya-Cano JL, Sluyter F, D'Souza U, Plomin R, et al. Hippocampal gene expression profiling across eight mouse inbred strains: towards understanding the molecular basis for behaviour. Eur J Neurosci. 2004;19:2576–2582. [PubMed]
10. Grice DE, Reenila I, Mannisto PT, Brooks AI, Smith GG, et al. Transcriptional profiling of C57 and DBA strains of mice in the absence and presence of morphine. BMC Genomics. 2007;8:76. [PMC free article] [PubMed]
11. Chesler EJ, Lu L, Shou S, Qu Y, Gu J, et al. Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function. Nat Genet. 2005;37:233–242. [PubMed]
12. Philip VM, Duvvuru S, Gomero B, Ansah TA, Blaha CD, et al. High-throughput behavioral phenotyping in the expanded panel of BXD recombinant inbred strains. Genes Brain Behav. 2009. [PMC free article] [PubMed]
13. Overall RW, Kempermann G, Peirce J, Lu L, Goldowitz D, et al. Genetics of the hippocampal transcriptome in mice: a systematic survey and online nerogenomic resource. Frontiers of Neurogenetics. 2009;1 [PMC free article] [PubMed]
14. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, et al. Initial sequencing and comparative analysis of the mouse genome. Nature. 2002;420:520–562. [PubMed]
15. Kress M, Barra Y, Seidman JG, Khoury G, Jay G. Functional insertion of an Alu type 2 (B2 SINE) repetitive sequence in murine class I genes. Science. 1984;226:974–977. [PubMed]
16. Georgiev GP. Mobile genetic elements in animal cells and their biological significance. Eur J Biochem. 1984;145:203–220. [PubMed]
17. Ferrigno O, Virolle T, Djabari Z, Ortonne JP, White RJ, et al. Transposable B2 SINE elements can provide mobile RNA polymerase II promoters. Nat Genet. 2001;28:77–81. [PubMed]
18. Tenhunen J, Ulmanen I. Production of rat soluble and membrane-bound catechol O-methyltransferase forms from bifunctional mRNAs. Biochem J. 1993;296(Pt 3):595–600. [PubMed]
19. Jones BC, Tarantino LM, Rodriguez LA, Reed CL, McClearn GE, et al. Quantitative-trait loci analysis of cocaine-related behaviours and neurochemistry. Pharmacogenetics. 1999;9:607–617. [PubMed]
20. Kanes S, Dains K, Cipp L, Gatley J, Hitzemann B, et al. Mapping the genes for haloperidol-induced catalepsy. J Pharmacol Exp Ther. 1996;277:1016–1025. [PubMed]
21. Demarest K, McCaughran J, Jr, Mahjubi E, Cipp L, Hitzemann R. Identification of an acute ethanol response quantitative trait locus on mouse chromosome 2. J Neurosci. 1999;19:549–561. [PubMed]
22. Wang J, Bixby JL. Receptor tyrosine phosphatase-delta is a homophilic, neurite-promoting cell adhesion molecular for CNS neurons. Mol Cell Neurosci. 1999;14:370–384. [PubMed]
23. Uetani N, Kato K, Ogura H, Mizuno K, Kawano K, et al. Impaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient mice. Embo J. 2000;19:2775–2785. [PubMed]
24. Hosak L. Role of the COMT gene Val158Met polymorphism in mental disorders: a review. Eur Psychiatry. 2007;22:276–281. [PubMed]
25. Straub RE, Lipska BK, Egan MF, Goldberg TE, Callicott JH, et al. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry. 2007;12:854–869. [PubMed]
26. Buckholtz JW, Sust S, Tan HY, Mattay VS, Straub RE, et al. fMRI evidence for functional epistasis between COMT and RGS4. Mol Psychiatry. 2007;12:893–895, 885. [PubMed]
27. Nicodemus KK, Kolachana BS, Vakkalanka R, Straub RE, Giegling I, et al. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Hum Genet. 2007;120:889–906. [PubMed]
28. Puls I, Mohr J, Wrase J, Priller J, Behr J, et al. Synergistic effects of the dopaminergic and glutamatergic system on hippocampal volume in alcohol-dependent patients. Biol Psychol. 2008;79:126–136. [PubMed]
29. Tan HY, Chen Q, Sust S, Buckholtz JW, Meyers JD, et al. Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function. Proc Natl Acad Sci U S A. 2007;104:12536–12541. [PubMed]
30. Papaleo F, Crawley JN, Song J, Lipska BK, Pickel J, et al. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J Neurosci. 2008;28:8709–8723. [PMC free article] [PubMed]
31. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, et al. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996;6:243–250. [PubMed]
32. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry. 1995;34:4202–4210. [PubMed]
33. Roth JA. Membrane-bound catechol-O-methyltransferase: a reevaluation of its role in the O-methylation of the catecholamine neurotransmitters. Rev Physiol Biochem Pharmacol. 1992;120:1–29. [PubMed]
34. Tunbridge EM, Harrison PJ, Weinberger DR. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry. 2006;60:141–151. [PubMed]
35. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A. 2001;98:6917–6922. [PubMed]
36. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, et al. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry. 2002;159:652–654. [PubMed]
37. Meyer-Lindenberg A, Kohn PD, Kolachana B, Kippenhan S, McInerney-Leo A, et al. Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat Neurosci. 2005;8:594–596. [PubMed]
38. Savitz J, Solms M, Ramesar R. The molecular genetics of cognition: dopamine, COMT and BDNF. Genes Brain Behav. 2006;5:311–328. [PubMed]
39. Bilder RM, Volavka J, Czobor P, Malhotra AK, Kennedy JL, et al. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry. 2002;52:701–707. [PubMed]
40. Goldman D, Oroszi G, Ducci F. The genetics of addictions: uncovering the genes. Nat Rev Genet. 2005;6:521–532. [PubMed]
41. Lee JY, Ji Z, Tian B. Phylogenetic analysis of mRNA polyadenylation sites reveals a role of transposable elements in evolution of the 3′-end of genes. Nucleic Acids Res. 2008;36:5581–5590. [PMC free article] [PubMed]
42. Koide T, Moriwaki K, Ikeda K, Niki H, Shiroishi T. Multi-phenotype behavioral characterization of inbred strains derived from wild stocks of Mus musculus. Mamm Genome. 2000;11:664–670. [PubMed]
43. Chesler EJ, Lu L, Wang J, Williams RW, Manly KF. WebQTL: rapid exploratory analysis of gene expression and genetic networks for brain and behavior. Nat Neurosci. 2004;7:485–486. [PubMed]
44. Wang J, Williams RW, Manly KF. WebQTL: web-based complex trait analysis. Neuroinformatics. 2003;1:299–308. [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science